Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2019

Sep 11, 2019

34975_dirs_2019-09-11_d02b73c8-8f0f-4a89-8ec5-e3ac36e3e841.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2019-09-10

Reporting Person: EDRICK ALAN I (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-09-10 Non-Qualified Stock Option (right to buy) $2.92 A 101800 Acquired 2029-09-10 Common Stock, par value $0.01 per share (101800) Direct

Footnotes

F1: The options vest in three equal installments on September 10, 2020, 2021 and 2022.